Patents by Inventor Salomé Adam

Salomé Adam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240352081
    Abstract: Disclosed are compounds, compositions, uses and methods using inhibitors of the CIP2A-TOPBP1 complex or agents that inhibit phosphopeptide recognition of TOPBP1 BRCT7/8, for treatment of a cancer associated with or characterized by a homologous recombination (HR) deficiency or treatment of cancer cells having HR deficiency.
    Type: Application
    Filed: January 30, 2024
    Publication date: October 24, 2024
    Inventors: Daniel Durocher, Salomé Adam, Silvia Emma Rossi, Yibo Xue
  • Patent number: 11897925
    Abstract: Disclosed are compounds, compositions, uses and methods using inhibitors of the CIP2A-TOPBP1 complex or agents that inhibit phosphopeptide recognition of TOPBP1 BRCT7/8, for treatment of a cancer associated with or characterized by a homologous recombination (HR) deficiency or treatment of cancer cells having HR deficiency.
    Type: Grant
    Filed: November 6, 2021
    Date of Patent: February 13, 2024
    Assignee: Sinai Health System
    Inventors: Daniel Durocher, Salomé Adam, Silvia Emma Rossi, Yibo Xue
  • Publication number: 20220153793
    Abstract: Disclosed are compounds, compositions, uses and methods using inhibitors of the CIP2A-TOPBP1 complex or agents that inhibit phosphopeptide recognition of TOPBP1 BRCT7/8, for treatment of a cancer associated with or characterized by a homologous recombination (HR) deficiency or treatment of cancer cells having HR deficiency.
    Type: Application
    Filed: November 6, 2021
    Publication date: May 19, 2022
    Inventors: Daniel Durocher, Salomé Adam, Silvia Emma Rossi, Yibo Xue